Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204202 · ClinicalTrials.gov registry record
PET Assessment of Acute Lung Transplant Rejection
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 28
- Enrollment target
NCT02204202: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT02204202 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02204202 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to gain understanding of the basic responses of the lungs to inflammation and specifically if there may be a better way to detect graft inflammation using non-invasive methods as well as to determine the effectiveness of immunosuppressive treatment regimens in preventing acute rejection in lung transplant recipients.
Interventions
- DRUG [18F]FDG
- DRUG [18F]ISO-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-02-04 |
Why NCT02204202 stopped before completion
NCT02204202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which [18F]FDG is the first listed.
NCT02204202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02204202 about?
NCT02204202 is a clinical study titled "PET Assessment of Acute Lung Transplant Rejection". The purpose of this research study is to gain understanding of the basic responses of the lungs to inflammation and specifically if there may be a better way to detect graft inflammation using non-invasive methods as well as to determine the effectiveness of immunosuppressive treatment regimens in p...
What is the current status of trial NCT02204202?
This trial is currently terminated. The enrollment target is 28 participants. The study started on 2014-02. Estimated completion is 2017-02-04.
What interventions are being tested in trial NCT02204202?
The interventions under investigation include: [18F]FDG (DRUG), [18F]ISO-1 (DRUG).
Who is sponsoring clinical trial NCT02204202?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia